Latest news with #SabinaLevi
Business Insider
08-07-2025
- Business
- Business Insider
Teva (TEVA) Receives a Buy from Leader Capital Markets
In a report released today, Sabina Levi from Leader Capital Markets maintained a Buy rating on Teva, with a price target of ILA9,300.00. The company's shares closed yesterday at ILA5,715.00. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Levi is an analyst with an average return of -7.3% and a 25.00% success rate. The analyst consensus on Teva is currently a Hold rating. The company has a one-year high of ILA8,431.00 and a one-year low of ILA4,865.00. Currently, Teva has an average volume of 2.11M.
Business Insider
05-07-2025
- Business
- Business Insider
Leader Capital Markets Keeps Their Buy Rating on Teva (TEVA)
Leader Capital Markets analyst Sabina Levi maintained a Buy rating on Teva today and set a price target of ILA9,300.00. The company's shares closed last Thursday at ILA5,721.00. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Levi is an analyst with an average return of -6.9% and a 25.00% success rate. The analyst consensus on Teva is currently a Hold rating. Based on Teva's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of ILA3.89 billion and a net profit of ILA214 million. In comparison, last year the company earned a revenue of ILA3.82 billion and had a GAAP net loss of ILA139 million
Business Insider
21-06-2025
- Business
- Business Insider
Leader Capital Markets Remains a Buy on Teva (TEVA)
In a report released today, Sabina Levi from Leader Capital Markets maintained a Buy rating on Teva (TEVA – Research Report), with a price target of ILA9,300.00. The company's shares closed last Thursday at ILA6,045.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Levi is ranked #6867 out of 9595 analysts. The analyst consensus on Teva is currently a Hold rating. Based on Teva's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of ILA3.89 billion and a net profit of ILA214 million. In comparison, last year the company earned a revenue of ILA3.82 billion and had a GAAP net loss of ILA139 million
Business Insider
17-06-2025
- Business
- Business Insider
Teva (TEVA) Gets a Buy from Leader Capital Markets
In a report released today, Sabina Levi from Leader Capital Markets maintained a Buy rating on Teva (TEVA – Research Report), with a price target of ILA9,300.00. The company's shares closed yesterday at ILA6,120.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Levi is ranked #6667 out of 9595 analysts. The analyst consensus on Teva is currently a Hold rating. The company has a one-year high of ILA8,431.00 and a one-year low of ILA4,865.00. Currently, Teva has an average volume of 1.93M.
Business Insider
10-06-2025
- Business
- Business Insider
Leader Capital Markets Reaffirms Their Buy Rating on Teva (TEVA)
Leader Capital Markets analyst Sabina Levi maintained a Buy rating on Teva (TEVA – Research Report) today and set a price target of ILA9,300.00. The company's shares closed yesterday at ILA6,281.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Levi is an analyst with an average return of -5.5% and a 0.00% success rate. The analyst consensus on Teva is currently a Hold rating. Based on Teva's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of ILA3.89 billion and a net profit of ILA214 million. In comparison, last year the company earned a revenue of ILA3.82 billion and had a GAAP net loss of ILA139 million
